Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hodgkin lymphoma treatment for older persons in the modern era
Andrew M. Evens, Marshall McKenna, Yun Kyoung Tiger, et al.
Hematology (2023) Vol. 2023, Iss. 1, pp. 483-499
Closed Access | Times Cited: 4

Showing 4 citing articles:

Brentuximab vedotin monotherapy is a feasible and effective treatment for older patients with classical Hodgkin lymphoma unsuitable for curative chemotherapy: Results from the prospective GHSG–NLG phase II BVB trial
Alexander Fosså, Daniel Molin, Paul J. Bröckelmann, et al.
HemaSphere (2025) Vol. 9, Iss. 3
Open Access
Treatment approaches for older Hodgkin lymphoma patients
Paul J. Bröckelmann
Current Opinion in Oncology (2024) Vol. 36, Iss. 5, pp. 353-359
Closed Access | Times Cited: 1
Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma
Pallawi Torka, Tatyana Feldman, Kerry J. Savage, et al.
Journal of Clinical Oncology (2024) Vol. 43, Iss. 8, pp. 985-993
Closed Access | Times Cited: 1
Nivolumab-containing therapy in patients with newly diagnosed classical Hodgkin lymphoma: own clinical observations and literature review
Д. Д. Иванова, Е. А. Baryakh, M. A. Mingalimov, et al.
Oncohematology (2024) Vol. 19, Iss. 4, pp. 52-72
Open Access
Page 1

Scroll to top